Sonoma Pharmaceuticals (SNOA) Return on Capital Employed Growth (5y) (2016 - 2026)
Sonoma Pharmaceuticals (SNOA) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 1.95 Mn | -445,560.06 | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 |
| Dec 31, 2025 | -208.00 |
| Sep 30, 2025 | 415.00 |
| Jun 30, 2025 | 1,979.00 |
| Mar 31, 2025 | 2,972.00 |
| Dec 31, 2024 | 1,174.00 |
| Sep 30, 2024 | 2,725.00 |
| Jun 30, 2024 | 3,774.00 |
| Mar 31, 2024 | 4,972.00 |
| Dec 31, 2023 | 6,737.00 |
| Sep 30, 2023 | 6,691.00 |
| Jun 30, 2023 | 5,825.00 |
| Mar 31, 2023 | 5,123.00 |
| Dec 31, 2022 | 1,623.00 |
| Sep 30, 2022 | 2,562.00 |
| Jun 30, 2022 | 1,690.00 |
| Mar 31, 2022 | 1,159.00 |
| Dec 31, 2021 | 5,763.00 |
| Sep 30, 2021 | 16,321.00 |
| Jun 30, 2021 | 10,631.00 |